beta-Adrenergic Agonist [EPC]

beta-Adrenergic Agonist [EPC] was reported 71959 times

Drugs of the beta-Adrenergic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NO DEVICE MALFUNCTION 60 0.9836
1 INJECTION SITE PALLOR 127 0.4019
2 VASCULAR ACCESS SITE COMPLICATION 99 0.3929
3 INFUSION SITE DISCHARGE 341 0.1943
4 ADMINISTRATION SITE SWELLING 61 0.1877
5 INFUSION SITE MASS 177 0.1628
6 INFUSION SITE BRUISING 326 0.1508
7 INFUSION SITE PRURITUS 458 0.1450
8 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 150 0.1412
9 INFUSION SITE URTICARIA 93 0.1388
10 LAGOPHTHALMOS 56 0.1369
11 INJECTION SITE ANAESTHESIA 44 0.1362
12 HEREDITARY ANGIOEDEMA 1432 0.1333
13 INFUSION SITE HAEMORRHAGE 385 0.1169
14 INFUSION SITE SCAR 51 0.1151
15 INFUSION SITE SWELLING 671 0.1065
16 INFUSION SITE RASH 146 0.1063
17 INJECTION SITE LACERATION 68 0.1061
18 INFUSION SITE DISCOMFORT 101 0.0974
19 ACCIDENTAL EXPOSURE 390 0.0936
20 LIQUID PRODUCT PHYSICAL ISSUE 678 0.0929
21 STEROID DEPENDENCE 79 0.0900
22 DEVICE FAILURE 1366 0.0896
23 INFUSION SITE NODULE 86 0.0895
24 TOXIC ANTERIOR SEGMENT SYNDROME 97 0.0889
25 CATARRH 79 0.0874
26 MULTIPLE ALLERGIES 642 0.0818
27 INFUSION SITE EXTRAVASATION 478 0.0767
28 MATERNAL EXPOSURE DURING DELIVERY 75 0.0757
29 ADMINISTRATION SITE PAIN 86 0.0746
30 INFUSION SITE ERYTHEMA 629 0.0745
31 INJECTION SITE COLDNESS 63 0.0743
32 INFUSION SITE PAIN 920 0.0713
33 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 66 0.0712
34 STRESS CARDIOMYOPATHY 404 0.0694
35 IMMUNISATION REACTION 48 0.0667
36 INCORRECT DRUG ADMINISTRATION RATE 284 0.0667
37 INFUSION SITE IRRITATION 84 0.0654
38 MAST CELL ACTIVATION SYNDROME 91 0.0648
39 INSURANCE ISSUE 968 0.0632
40 KOUNIS SYNDROME 139 0.0612
41 INFUSION SITE WARMTH 74 0.0604
42 INFUSION SITE DISCOLOURATION 53 0.0602
43 ALLERGIC SINUSITIS 51 0.0594
44 DEVICE INFUSION ISSUE 147 0.0592
45 VASOPLEGIA SYNDROME 97 0.0591
46 INJECTION SITE HYPOAESTHESIA 83 0.0580
47 SEASONAL ALLERGY 805 0.0568
48 VASOCONSTRICTION 48 0.0549
49 INFUSION SITE OEDEMA 45 0.0538
50 INFECTED BITE 45 0.0530
51 BURNS SECOND DEGREE 87 0.0495
52 ARTHROPOD STING 81 0.0486
53 INFUSION SITE REACTION 145 0.0485
54 POOR VENOUS ACCESS 477 0.0461
55 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 62 0.0459
56 PHARYNGEAL SWELLING 444 0.0453
57 SINUSITIS BACTERIAL 45 0.0427
58 RESTRICTIVE PULMONARY DISEASE 48 0.0410
59 SINUSITIS 4107 0.0400
60 EAR INFECTION 1049 0.0394
61 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 85 0.0387
62 NOROVIRUS INFECTION 55 0.0381
63 INFUSION SITE INDURATION 55 0.0371
64 NASAL DISCHARGE DISCOLOURATION 51 0.0370
65 PULSELESS ELECTRICAL ACTIVITY 152 0.0363
66 OBSTRUCTION 144 0.0360
67 CHRONIC SINUSITIS 135 0.0359
68 DERMATITIS CONTACT 399 0.0350
69 FOOD ALLERGY 266 0.0344
70 DISTRIBUTIVE SHOCK 78 0.0344
71 RESPIRATORY TRACT INFECTION 881 0.0338
72 VEIN RUPTURE 56 0.0334
73 ARTERIOSPASM CORONARY 134 0.0334
74 UPPER RESPIRATORY TRACT INFECTION 1511 0.0327
75 BODY TEMPERATURE ABNORMAL 60 0.0326
76 EXPIRED DRUG ADMINISTERED 160 0.0323
77 HYPOPNOEA 111 0.0320
78 CENTRAL VENOUS CATHETERISATION 91 0.0301
79 PRODUCT DISTRIBUTION ISSUE 279 0.0300
80 RHINITIS 241 0.0299
81 ANAESTHETIC COMPLICATION 79 0.0294
82 PRODUCT COLOUR ISSUE 151 0.0294
83 PHARYNGITIS STREPTOCOCCAL 315 0.0291
84 RESPIRATORY TRACT INFECTION VIRAL 67 0.0287
85 ANIMAL BITE 75 0.0281
86 CATHETER SITE PAIN 73 0.0281
87 ANAPHYLACTIC REACTION 1552 0.0281
88 GASTROENTERITIS VIRAL 506 0.0280
89 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 92 0.0278
90 PARANASAL SINUS DISCOMFORT 103 0.0272
91 EXTREMITY NECROSIS 47 0.0269
92 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 181 0.0266
93 IMPAIRED QUALITY OF LIFE 376 0.0261
94 CARDIOGENIC SHOCK 371 0.0258
95 HYPERLACTACIDAEMIA 69 0.0257
96 STREPTOCOCCAL INFECTION 140 0.0251
97 PERIPHERAL ISCHAEMIA 99 0.0242
98 SKIN ABRASION 114 0.0241
99 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 63 0.0240
100 WEIGHT FLUCTUATION 251 0.0240
101 STRIDOR 70 0.0238
102 SKIN INFECTION 264 0.0235
103 MIDDLE EAR EFFUSION 50 0.0226
104 TOOTH INFECTION 298 0.0226
105 BRONCHITIS 1669 0.0225
106 LYME DISEASE 75 0.0225
107 EYE INFECTION 253 0.0224
108 BRONCHIECTASIS 148 0.0219
109 OXYGEN SATURATION ABNORMAL 61 0.0215
110 BLOOD IMMUNOGLOBULIN E INCREASED 52 0.0215
111 VASCULAR DEVICE INFECTION 96 0.0211
112 ORAL PRURITUS 48 0.0209
113 NEEDLE ISSUE 608 0.0209
114 RESPIRATORY ACIDOSIS 82 0.0208
115 RHINOVIRUS INFECTION 81 0.0208
116 SKIN LACERATION 226 0.0208
117 VIRAL INFECTION 691 0.0207
118 COMPARTMENT SYNDROME 54 0.0207
119 ARTHROPOD BITE 153 0.0206
120 GASTROINTESTINAL INFECTION 185 0.0206
121 HAEMODYNAMIC INSTABILITY 157 0.0206
122 BLOOD IMMUNOGLOBULIN G DECREASED 51 0.0206
123 INJECTION SITE INJURY 114 0.0205
124 HYPERCAPNIA 61 0.0202
125 VENTRICULAR HYPOKINESIA 65 0.0202
126 PRODUCT PACKAGING CONFUSION 49 0.0202
127 CORNEAL OEDEMA 45 0.0201
128 MENINGITIS ASEPTIC 90 0.0200
129 UPPER-AIRWAY COUGH SYNDROME 165 0.0200
130 INFUSION SITE INFECTION 46 0.0198
131 FOOD POISONING 106 0.0198
132 SINUS DISORDER 391 0.0197
133 RESPIRATORY SYNCYTIAL VIRUS INFECTION 171 0.0196
134 FORCED EXPIRATORY VOLUME DECREASED 55 0.0194
135 SUSPECTED COVID-19 64 0.0194
136 HORDEOLUM 83 0.0192
137 INFUSION RELATED REACTION 1248 0.0188
138 HAEMATOLOGICAL INFECTION 45 0.0184
139 VENTRICULAR FIBRILLATION 201 0.0181
140 KIDNEY INFECTION 355 0.0181
141 BLOOD LACTIC ACID INCREASED 95 0.0180
142 APLASTIC ANAEMIA 94 0.0180
143 PRODUCT ADMINISTRATION INTERRUPTED 141 0.0179
144 RHINITIS ALLERGIC 79 0.0177
145 VENTRICULAR TACHYCARDIA 289 0.0175
146 GASTRIC INFECTION 66 0.0172
147 ALCOHOL POISONING 46 0.0172
148 SINUS CONGESTION 232 0.0172
149 FEAR 461 0.0171
150 VENTRICULAR ARRHYTHMIA 62 0.0169
151 PRE-EXISTING CONDITION IMPROVED 105 0.0168
152 PULSE ABSENT 79 0.0166
153 TOOTH ABSCESS 169 0.0166
154 TENDERNESS 170 0.0163
155 ASTHMA 1835 0.0162
156 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 83 0.0162
157 PAROSMIA 122 0.0162
158 MULTI-ORGAN FAILURE 278 0.0161
159 CARDIAC MURMUR 139 0.0160
160 ATYPICAL PNEUMONIA 48 0.0160
161 PARANASAL SINUS HYPERSECRETION 61 0.0160
162 PHARYNGITIS 198 0.0159
163 ORAL INFECTION 62 0.0158
164 ILLNESS 1634 0.0158
165 INJECTION SITE SCAR 45 0.0158
166 CONCUSSION 121 0.0156
167 RESPIRATORY TRACT CONGESTION 245 0.0154
168 COVID-19 2689 0.0153
169 VITAMIN B12 DEFICIENCY 62 0.0153
170 LARYNGEAL OEDEMA 94 0.0152
171 SWOLLEN TONGUE 476 0.0152
172 LIGAMENT SPRAIN 150 0.0152
173 POST PROCEDURAL INFECTION 123 0.0151
174 BRAIN FOG 236 0.0150
175 PSEUDOMONAS INFECTION 129 0.0150
176 MYASTHENIA GRAVIS 117 0.0145
177 POST-TRAUMATIC STRESS DISORDER 97 0.0145
178 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 242 0.0142
179 ANAPHYLACTIC SHOCK 366 0.0142
180 SINUS TACHYCARDIA 200 0.0141
181 ELECTROCARDIOGRAM ABNORMAL 110 0.0140
182 ISCHAEMIA 64 0.0139
183 MOUTH SWELLING 80 0.0139
184 CYSTITIS 438 0.0137
185 THROAT TIGHTNESS 368 0.0136
186 VEIN DISORDER 68 0.0136
187 CANDIDA INFECTION 229 0.0135
188 BRONCHOSPASM 193 0.0135
189 PRODUCT QUALITY ISSUE 1832 0.0135
190 LOCALISED INFECTION 325 0.0134
191 BLOOD PRESSURE SYSTOLIC DECREASED 61 0.0134
192 COVID-19 PNEUMONIA 158 0.0134
193 INFLUENZA 1484 0.0133
194 OBSTRUCTIVE AIRWAYS DISORDER 147 0.0132
195 PRODUCTIVE COUGH 628 0.0131
196 SENSITIVE SKIN 97 0.0131
197 LIMB INJURY 355 0.0131
198 ANGIOEDEMA 578 0.0131
199 HYPERVOLAEMIA 64 0.0129
200 ARTHRITIS INFECTIVE 60 0.0129
201 FUNGAL INFECTION 431 0.0129
202 THROAT CLEARING 48 0.0128
203 RENAL INJURY 379 0.0127
204 PHARYNGEAL OEDEMA 196 0.0127
205 INJURY ASSOCIATED WITH DEVICE 259 0.0127
206 POST PROCEDURAL COMPLICATION 244 0.0127
207 GINGIVAL PAIN 101 0.0127
208 BACTERIAL INFECTION 236 0.0126
209 NEPHROGENIC ANAEMIA 58 0.0125
210 NASOPHARYNGITIS 2305 0.0125
211 ANHEDONIA 328 0.0125
212 RALES 72 0.0124
213 WHEEZING 730 0.0123
214 SHOCK 283 0.0123
215 MIGRAINE 1164 0.0122
216 CARDIAC ARREST 1003 0.0121
217 VITAMIN D DEFICIENCY 118 0.0121
218 NASAL CONGESTION 707 0.0120
219 HEART RATE ABNORMAL 67 0.0120
220 URINARY TRACT INFECTION 2041 0.0120
221 PARAESTHESIA ORAL 172 0.0119
222 BLOOD PRESSURE DIASTOLIC DECREASED 88 0.0119
223 SNORING 45 0.0119
224 LIP SWELLING 395 0.0118
225 HAND FRACTURE 84 0.0118
226 MONOCYTE COUNT INCREASED 43 0.0118
227 URTICARIA 1971 0.0118
228 BREATH SOUNDS ABNORMAL 58 0.0118
229 BRADYCARDIA 614 0.0116
230 EAR DISORDER 53 0.0116
231 PRODUCT DOSE OMISSION ISSUE 3384 0.0115
232 SCRATCH 121 0.0115
233 EXPIRED PRODUCT ADMINISTERED 381 0.0115
234 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2065 0.0114
235 SENSITIVITY TO WEATHER CHANGE 60 0.0114
236 SPUTUM DISCOLOURED 108 0.0114
237 BLOOD PRESSURE ABNORMAL 226 0.0114
238 SINUS HEADACHE 67 0.0113
239 ACIDOSIS 86 0.0112
240 THERMAL BURN 79 0.0111
241 DEVICE RELATED INFECTION 171 0.0111
242 SUPRAVENTRICULAR TACHYCARDIA 106 0.0111
243 OROPHARYNGEAL DISCOMFORT 100 0.0111
244 STAPHYLOCOCCAL INFECTION 364 0.0110
245 PNEUMONIA BACTERIAL 101 0.0110
246 ENDOPHTHALMITIS 66 0.0110
247 METABOLIC ACIDOSIS 347 0.0108
248 SUSPECTED OFF LABEL USE 49 0.0108
249 MUSCLE STRAIN 93 0.0107
250 LEFT VENTRICULAR DYSFUNCTION 72 0.0107
251 SCAR 184 0.0107
252 NORMAL NEWBORN 58 0.0107
253 FOOT FRACTURE 201 0.0106
254 DEVICE USE ISSUE 185 0.0106
255 MYOCARDIAL ISCHAEMIA 119 0.0104
256 CARDIOTOXICITY 93 0.0104
257 ACCIDENTAL EXPOSURE TO PRODUCT 1073 0.0104
258 EAR PAIN 202 0.0104
259 CATHETERISATION CARDIAC 46 0.0104
260 NASAL POLYPS 51 0.0103
261 HEPARIN-INDUCED THROMBOCYTOPENIA 51 0.0103
262 NASAL DISCOMFORT 82 0.0103
263 INJECTION SITE DISCOLOURATION 129 0.0103
264 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 177 0.0103
265 JOINT INJURY 220 0.0103
266 TROPONIN INCREASED 78 0.0102
267 ATTENTION DEFICIT HYPERACTIVITY DISORDER 43 0.0102
268 INTENTIONAL PRODUCT USE ISSUE 889 0.0101
269 PRODUCT DOSE OMISSION IN ERROR 286 0.0101
270 BRAIN INJURY 101 0.0101
271 INABILITY TO AFFORD MEDICATION 100 0.0101
272 POSTOPERATIVE WOUND INFECTION 68 0.0101
273 INJECTION SITE DISCHARGE 54 0.0100
274 GINGIVITIS 54 0.0100
275 HYPOXIA 352 0.0100
276 LIGAMENT RUPTURE 44 0.0100
277 VENTRICULAR EXTRASYSTOLES 103 0.0099
278 ESCHERICHIA INFECTION 81 0.0098
279 UMBILICAL HERNIA 46 0.0098
280 INFECTION 1424 0.0098
281 THROAT IRRITATION 441 0.0098
282 RESPIRATORY DISTRESS 271 0.0098
283 HYPERAESTHESIA 80 0.0097
284 HEART RATE INCREASED 961 0.0097
285 UNEVALUABLE EVENT 729 0.0096
286 ACUTE PULMONARY OEDEMA 54 0.0096
287 RESPIRATION ABNORMAL 66 0.0096
288 PERIORBITAL SWELLING 54 0.0095
289 TACHYCARDIA 848 0.0095
290 CIRCULATORY COLLAPSE 162 0.0095
291 WRIST FRACTURE 114 0.0095
292 WOUND INFECTION 104 0.0095
293 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 493 0.0094
294 LIVE BIRTH 79 0.0094
295 RESPIRATORY DISORDER 282 0.0094
296 OROPHARYNGEAL PAIN 866 0.0093
297 BODY HEIGHT DECREASED 100 0.0093
298 AUTOIMMUNE DISORDER 91 0.0093
299 CHEST DISCOMFORT 955 0.0093
300 SNEEZING 209 0.0093
301 ATELECTASIS 90 0.0093
302 SINUS BRADYCARDIA 90 0.0093
303 FLANK PAIN 87 0.0093
304 VIRAL UPPER RESPIRATORY TRACT INFECTION 44 0.0092
305 INJURY 648 0.0092
306 TEMPERATURE INTOLERANCE 95 0.0092
307 ORAL CANDIDIASIS 121 0.0092
308 SLEEP APNOEA SYNDROME 175 0.0092
309 CONJUNCTIVITIS 170 0.0092
310 FACIAL PARALYSIS 78 0.0091
311 INTESTINAL ISCHAEMIA 50 0.0091
312 FACIAL PAIN 81 0.0091
313 ENDOMETRIOSIS 43 0.0090
314 OXYGEN SATURATION DECREASED 505 0.0090
315 NEPHROLITHIASIS 408 0.0089
316 ACUTE RESPIRATORY DISTRESS SYNDROME 157 0.0089
317 CONTUSION 852 0.0088
318 NERVE COMPRESSION 81 0.0088
319 MUSCULOSKELETAL DISCOMFORT 151 0.0088
320 DIVERTICULITIS 243 0.0088
321 PLEURISY 52 0.0087
322 CELLULITIS 438 0.0087
323 ECZEMA 454 0.0087
324 SKIN NECROSIS 45 0.0087
325 RESPIRATORY RATE INCREASED 77 0.0087
326 APHONIA 121 0.0087
327 COUGH 2431 0.0087
328 HYPERSENSITIVITY 1608 0.0087
329 BODY TEMPERATURE DECREASED 85 0.0086
330 PNEUMONIA 2782 0.0086
331 BLOOD PRESSURE SYSTOLIC INCREASED 167 0.0086
332 VITAMIN D DECREASED 73 0.0085
333 HYPOTENSION 1708 0.0085
334 IMPAIRED GASTRIC EMPTYING 116 0.0085
335 SARS-COV-2 TEST POSITIVE 112 0.0085
336 RHINORRHOEA 548 0.0085
337 SECRETION DISCHARGE 106 0.0085
338 ANKLE FRACTURE 131 0.0085
339 SPINAL DISORDER 80 0.0084
340 LACTIC ACIDOSIS 273 0.0084
341 HEAD INJURY 266 0.0084
342 ORAL HERPES 164 0.0084
343 CLOSTRIDIUM DIFFICILE INFECTION 183 0.0084
344 SWELLING 784 0.0084
345 BLOOD PRESSURE INCREASED 1279 0.0084
346 EMPHYSEMA 84 0.0083
347 PULMONARY MASS 124 0.0083
348 PULMONARY HAEMORRHAGE 65 0.0083
349 CHILLS 971 0.0083
350 CARPAL TUNNEL SYNDROME 115 0.0082
351 CYANOSIS 129 0.0082
352 PNEUMOTHORAX 130 0.0082
353 ATRIAL FLUTTER 65 0.0081
354 MIDDLE INSOMNIA 152 0.0081
355 BODY TEMPERATURE INCREASED 166 0.0081
356 SPINAL OPERATION 99 0.0080
357 APNOEA 62 0.0080
358 SWELLING OF EYELID 50 0.0080
359 LOW BIRTH WEIGHT BABY 63 0.0079
360 HYPOAESTHESIA ORAL 118 0.0078
361 PARALYSIS 112 0.0078
362 HEART RATE DECREASED 273 0.0078
363 FIBROMYALGIA 189 0.0078
364 SCOLIOSIS 48 0.0077
365 HYPOVOLAEMIA 45 0.0077
366 HEADACHE 4812 0.0077
367 DYSPNOEA EXERTIONAL 287 0.0076
368 PULMONARY THROMBOSIS 83 0.0076
369 SWELLING FACE 494 0.0076
370 DERMATITIS ATOPIC 400 0.0076
371 WALKING AID USER 50 0.0076
372 SKIN WARM 44 0.0076
373 MUSCULOSKELETAL CHEST PAIN 117 0.0076
374 RIB FRACTURE 155 0.0075
375 PRODUCT LABEL ISSUE 51 0.0075
376 MASS 105 0.0075
377 RESPIRATORY DEPRESSION 92 0.0075
378 MENINGITIS 50 0.0075
379 BLOOD PRESSURE DECREASED 497 0.0075
380 EYELID PTOSIS 76 0.0075
381 INTERVERTEBRAL DISC DEGENERATION 69 0.0074
382 MULTIPLE ORGAN DYSFUNCTION SYNDROME 211 0.0074
383 BACK DISORDER 121 0.0074
384 ANURIA 64 0.0074
385 DECREASED ACTIVITY 80 0.0074
386 EAR DISCOMFORT 76 0.0074
387 NEURALGIA 180 0.0074
388 HERNIA 143 0.0074
389 EYE SWELLING 275 0.0074
390 LACRIMATION INCREASED 223 0.0074
391 DECUBITUS ULCER 60 0.0074
392 MUSCLE TIGHTNESS 119 0.0073
393 EYE INFLAMMATION 70 0.0073
394 BLOOD IRON DECREASED 87 0.0073
395 PULMONARY OEDEMA 328 0.0073
396 URINE OUTPUT DECREASED 64 0.0073
397 ROTATOR CUFF SYNDROME 94 0.0073
398 DEVICE OCCLUSION 103 0.0073
399 PRODUCT PREPARATION ISSUE 48 0.0073
400 ASPERGILLUS INFECTION 48 0.0073
401 FEELING JITTERY 139 0.0073
402 UNRESPONSIVE TO STIMULI 188 0.0073
403 ACUTE RESPIRATORY FAILURE 140 0.0073
404 TORSADE DE POINTES 57 0.0073
405 HIATUS HERNIA 94 0.0073
406 TOOTH FRACTURE 80 0.0072
407 WRONG PRODUCT ADMINISTERED 49 0.0072
408 GENERALISED TONIC-CLONIC SEIZURE 120 0.0072
409 MITRAL VALVE INCOMPETENCE 82 0.0072
410 FEAR OF INJECTION 51 0.0071
411 GANGRENE 43 0.0071
412 PRODUCT AVAILABILITY ISSUE 162 0.0071
413 INJECTION SITE SWELLING 543 0.0071
414 BLOOD MAGNESIUM DECREASED 61 0.0071
415 NECK PAIN 395 0.0071
416 IMPAIRED WORK ABILITY 151 0.0071
417 PULMONARY CONGESTION 93 0.0070
418 COAGULOPATHY 117 0.0070
419 ATRIOVENTRICULAR BLOCK 54 0.0070
420 PALPITATIONS 818 0.0070
421 ULCER 111 0.0070
422 BRAIN OEDEMA 88 0.0070
423 PALLOR 189 0.0069
424 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 380 0.0069
425 TACHYPNOEA 94 0.0069
426 EJECTION FRACTION DECREASED 107 0.0069
427 INFLUENZA LIKE ILLNESS 566 0.0069
428 VERTIGO 419 0.0069
429 HERPES ZOSTER 395 0.0069
430 MYDRIASIS 88 0.0069
431 PYREXIA 2369 0.0068
432 EYE PRURITUS 230 0.0068
433 POOR QUALITY SLEEP 147 0.0068
434 COMPLICATION ASSOCIATED WITH DEVICE 99 0.0068
435 LYMPHOEDEMA 47 0.0068
436 SENSATION OF FOREIGN BODY 57 0.0068
437 WEIGHT DECREASED 1887 0.0068
438 ADRENAL INSUFFICIENCY 82 0.0068
439 ASPIRATION 74 0.0067
440 BLOOD PRESSURE FLUCTUATION 162 0.0067
441 DYSPNOEA 3814 0.0067
442 WRONG DRUG ADMINISTERED 60 0.0067
443 FEELING COLD 187 0.0067
444 LUNG INFECTION 104 0.0067
445 FURUNCLE 53 0.0067
446 FREQUENT BOWEL MOVEMENTS 180 0.0067
447 OSTEOMYELITIS 120 0.0066
448 CYST 82 0.0066
449 PREMATURE DELIVERY 105 0.0066
450 PRODUCT USE ISSUE 1236 0.0066
451 RIGHT VENTRICULAR FAILURE 46 0.0066
452 CARDIOMYOPATHY 97 0.0066
453 ARTHRITIS 516 0.0066
454 DYSPHONIA 382 0.0065
455 INTENTIONAL DOSE OMISSION 186 0.0065
456 PROCEDURAL COMPLICATION 50 0.0065
457 BLOOD POTASSIUM DECREASED 196 0.0065
458 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 313 0.0065
459 SCAB 74 0.0065
460 ANXIETY 1833 0.0064
461 FULL BLOOD COUNT ABNORMAL 68 0.0064
462 ATRIOVENTRICULAR BLOCK COMPLETE 43 0.0064
463 RENAL FAILURE 853 0.0064
464 ACUTE MYOCARDIAL INFARCTION 189 0.0064
465 THERAPY CHANGE 63 0.0064
466 ACCIDENTAL OVERDOSE 234 0.0064
467 HYSTERECTOMY 55 0.0063
468 CHEST PAIN 1176 0.0063
469 BLADDER DISORDER 63 0.0063
470 HEAD DISCOMFORT 112 0.0063
471 FALL 2100 0.0063
472 THERAPY NON-RESPONDER 283 0.0063
473 RESPIRATORY FAILURE 457 0.0063
474 OEDEMA 339 0.0062
475 EOSINOPHIL COUNT INCREASED 52 0.0062
476 INTERVERTEBRAL DISC PROTRUSION 136 0.0062
477 TINNITUS 285 0.0062
478 INJECTION SITE DISCOMFORT 65 0.0062
479 GASTROINTESTINAL DISORDER 553 0.0062
480 TRICUSPID VALVE INCOMPETENCE 49 0.0062
481 PROCEDURAL PAIN 171 0.0062
482 INJECTION SITE EXTRAVASATION 76 0.0062
483 LYMPHADENOPATHY 218 0.0062
484 ACUTE CORONARY SYNDROME 51 0.0062
485 PRURITUS 2361 0.0061
486 GASTROOESOPHAGEAL REFLUX DISEASE 493 0.0061
487 SKIN SWELLING 53 0.0061
488 WEIGHT INCREASED 1367 0.0061
489 BLOOD SODIUM DECREASED 115 0.0061
490 PRESCRIBED OVERDOSE 118 0.0061
491 CATARACT 363 0.0061
492 ROAD TRAFFIC ACCIDENT 255 0.0061
493 PNEUMONIA ASPIRATION 152 0.0061
494 UPPER LIMB FRACTURE 121 0.0061
495 BACK INJURY 66 0.0061
496 NEUTROPHIL COUNT INCREASED 62 0.0060
497 PRODUCT USE IN UNAPPROVED INDICATION 1499 0.0060
498 PAIN 3684 0.0060
499 BURNING SENSATION 420 0.0060
500 PRODUCT USE COMPLAINT 94 0.0060
501 BACK PAIN 1386 0.0060
502 PULMONARY HYPERTENSION 124 0.0059
503 DISCOMFORT 361 0.0059
504 SYSTEMIC LUPUS ERYTHEMATOSUS 210 0.0059
505 THYROID DISORDER 91 0.0059
506 SKIN CANCER 127 0.0059
507 BACTERAEMIA 70 0.0059
508 HYPERSOMNIA 169 0.0059
509 LIMB DISCOMFORT 182 0.0059
510 SEPSIS 656 0.0059
511 LOSS OF CONSCIOUSNESS 753 0.0059
512 FATIGUE 4561 0.0059
513 MIOSIS 47 0.0059
514 FEELING HOT 359 0.0059
515 IRON DEFICIENCY ANAEMIA 54 0.0058
516 LOWER RESPIRATORY TRACT INFECTION 266 0.0058
517 PANIC ATTACK 213 0.0058
518 POST PROCEDURAL HAEMORRHAGE 68 0.0058
519 RASH MACULAR 204 0.0058
520 SLEEP DISORDER 411 0.0058
521 QUALITY OF LIFE DECREASED 78 0.0058
522 DRY EYE 290 0.0058
523 TOOTHACHE 105 0.0058
524 PRODUCT PRESCRIBING ISSUE 126 0.0058
525 ANAL INCONTINENCE 52 0.0058
526 PELVIC FRACTURE 45 0.0058
527 RESTLESS LEGS SYNDROME 105 0.0058
528 JOINT DISLOCATION 61 0.0058
529 BURSITIS 70 0.0058
530 NERVE INJURY 64 0.0058
531 GENERALISED OEDEMA 71 0.0057
532 SKIN HAEMORRHAGE 85 0.0057
533 RENAL TUBULAR NECROSIS 56 0.0057
534 DYSPHAGIA 541 0.0057
535 EXOSTOSIS 52 0.0057
536 THROMBOSIS 458 0.0057
537 KNEE OPERATION 56 0.0057
538 IMMUNE SYSTEM DISORDER 75 0.0057
539 HYPERLIPIDAEMIA 68 0.0057
540 DISSEMINATED INTRAVASCULAR COAGULATION 80 0.0057
541 BLOOD ALBUMIN DECREASED 45 0.0057
542 PERIPHERAL SWELLING 873 0.0057
543 RASH PRURITIC 306 0.0056
544 ELECTROCARDIOGRAM QT PROLONGED 203 0.0056
545 ATRIAL FIBRILLATION 549 0.0056
546 INJECTION SITE URTICARIA 138 0.0056
547 COLD SWEAT 99 0.0056
548 OCULAR DISCOMFORT 63 0.0056
549 LUNG DISORDER 275 0.0056
550 SMALL INTESTINAL OBSTRUCTION 69 0.0056
551 PREGNANCY 112 0.0056
552 PRODUCT ADMINISTRATION ERROR 113 0.0056
553 BLOOD UREA INCREASED 93 0.0055
554 TUBULOINTERSTITIAL NEPHRITIS 104 0.0055
555 HEART RATE IRREGULAR 125 0.0055
556 FEEDING DISORDER 112 0.0055
557 SKELETAL INJURY 57 0.0055
558 SEIZURE 636 0.0055
559 MUSCULAR WEAKNESS 625 0.0055
560 SKIN FISSURES 107 0.0055
561 MATERNAL EXPOSURE DURING PREGNANCY 488 0.0055
562 DRUG EFFECT LESS THAN EXPECTED 81 0.0055
563 PERIPHERAL COLDNESS 75 0.0055
564 SKIN DISCOLOURATION 251 0.0055
565 ABSCESS 87 0.0054
566 CARDIO-RESPIRATORY ARREST 228 0.0054
567 WOUND 152 0.0054
568 HYPOTHERMIA 55 0.0054
569 ABDOMINAL DISTENSION 567 0.0054
570 PRESYNCOPE 132 0.0054
571 FLUSHING 551 0.0054
572 INJECTION SITE BRUISING 432 0.0054
573 HYPERTENSION 1145 0.0054
574 SEPTIC SHOCK 235 0.0054
575 RASH 2352 0.0054
576 SPINAL FRACTURE 108 0.0054
577 EYE DISCHARGE 56 0.0054
578 CARDIOMEGALY 66 0.0054
579 BIPOLAR DISORDER 58 0.0053
580 ERYTHEMA 1093 0.0053
581 STATUS EPILEPTICUS 60 0.0053
582 PRODUCT PACKAGING ISSUE 50 0.0053
583 EATING DISORDER 112 0.0053
584 MENTAL STATUS CHANGES 146 0.0053
585 INJECTION SITE PRURITUS 352 0.0052
586 RENAL IMPAIRMENT 440 0.0052
587 TREMOR 867 0.0052
588 TOOTH EXTRACTION 65 0.0052
589 LOWER LIMB FRACTURE 100 0.0052
590 INJECTION SITE PAIN 1594 0.0052
591 EXPOSURE DURING PREGNANCY 322 0.0052
592 DEHYDRATION 691 0.0052
593 RASH ERYTHEMATOUS 247 0.0052
594 ELECTROLYTE IMBALANCE 60 0.0052
595 HAEMOPTYSIS 144 0.0052
596 PHOTOPHOBIA 97 0.0052
597 ECONOMIC PROBLEM 78 0.0051
598 COMA 245 0.0051
599 SCIATICA 82 0.0051
600 INCREASED TENDENCY TO BRUISE 47 0.0051
601 GALLBLADDER DISORDER 91 0.0051
602 PAIN IN EXTREMITY 1502 0.0051
603 CHOKING 99 0.0051
604 RED BLOOD CELL SEDIMENTATION RATE INCREASED 56 0.0051
605 CARDIAC DISORDER 473 0.0051
606 HYPOAESTHESIA 756 0.0050
607 ARRHYTHMIA 239 0.0050
608 INJECTION SITE ERYTHEMA 623 0.0050
609 INTENTIONAL OVERDOSE 322 0.0050
610 HAEMATOMA 130 0.0050
611 DIPLOPIA 130 0.0050
612 GASTROINTESTINAL PAIN 55 0.0050
613 LACERATION 47 0.0050
614 TOOTH DISORDER 111 0.0050
615 VITREOUS FLOATERS 49 0.0050
616 OSTEOPOROSIS 205 0.0050
617 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44 0.0050
618 SYNCOPE 497 0.0050
619 OBESITY 79 0.0050
620 CONDITION AGGRAVATED 1507 0.0050
621 WHITE BLOOD CELL COUNT INCREASED 190 0.0049
622 COORDINATION ABNORMAL 69 0.0049
623 IRRITABLE BOWEL SYNDROME 106 0.0049
624 HAEMORRHOIDS 96 0.0049
625 DRUG INEFFECTIVE 6469 0.0049
626 MALAISE 2152 0.0049
627 NODULE 64 0.0049
628 RED BLOOD CELL COUNT DECREASED 140 0.0049
629 DEVICE MALFUNCTION 344 0.0049
630 BLOOD CALCIUM DECREASED 55 0.0049
631 SPEECH DISORDER 256 0.0049
632 THERAPEUTIC RESPONSE SHORTENED 162 0.0049
633 ACCIDENT 58 0.0049
634 LETHARGY 278 0.0048
635 INJECTION SITE HAEMATOMA 70 0.0048
636 INJECTION SITE RASH 148 0.0048
637 RASH PAPULAR 108 0.0048
638 SURGERY 281 0.0048
639 VOMITING 2250 0.0048
640 NAUSEA 3782 0.0048
641 DIZZINESS POSTURAL 46 0.0047
642 CHOLECYSTECTOMY 54 0.0047
643 PHOTOSENSITIVITY REACTION 78 0.0047
644 INJECTION SITE HAEMORRHAGE 377 0.0047
645 ARTHRALGIA 1956 0.0047
646 LEUKOCYTOSIS 85 0.0047
647 PREMATURE BABY 141 0.0047
648 GOUT 84 0.0047
649 HYPERTENSIVE CRISIS 52 0.0047
650 THERAPY INTERRUPTED 333 0.0047
651 EPISTAXIS 348 0.0046
652 HYPERHIDROSIS 599 0.0046
653 PERICARDIAL EFFUSION 107 0.0046
654 MUSCLE SPASMS 848 0.0046
655 DIZZINESS 2303 0.0046
656 DEEP VEIN THROMBOSIS 300 0.0046
657 HYPOKINESIA 67 0.0046
658 NEOPLASM 53 0.0046
659 SLUGGISHNESS 47 0.0046
660 GASTRITIS 121 0.0046
661 FLUID RETENTION 233 0.0046
662 NIGHTMARE 158 0.0046
663 PARAESTHESIA 717 0.0046
664 FEELING ABNORMAL 1091 0.0045
665 ABDOMINAL DISCOMFORT 763 0.0045
666 NEUROPATHY PERIPHERAL 432 0.0045
667 DYSURIA 167 0.0045
668 NERVOUSNESS 237 0.0045
669 RETCHING 96 0.0045
670 MEDICATION ERROR 250 0.0045
671 NERVOUS SYSTEM DISORDER 140 0.0045
672 INJECTION SITE IRRITATION 57 0.0045
673 DEPRESSED LEVEL OF CONSCIOUSNESS 177 0.0045
674 EYELID OEDEMA 52 0.0045
675 RECTAL HAEMORRHAGE 192 0.0045
676 PULMONARY EMBOLISM 424 0.0045
677 OCULAR HYPERAEMIA 211 0.0044
678 RENAL PAIN 47 0.0044
679 DENTAL CARIES 49 0.0044
680 EYE PAIN 249 0.0044
681 PAIN IN JAW 125 0.0044
682 DYSARTHRIA 166 0.0044
683 INJECTION SITE REACTION 303 0.0044
684 HAEMATOCHEZIA 243 0.0044
685 HEPATIC STEATOSIS 82 0.0044
686 HAEMATOCRIT DECREASED 87 0.0044
687 COLITIS ULCERATIVE 196 0.0044
688 INTESTINAL OBSTRUCTION 165 0.0044
689 TRANSIENT ISCHAEMIC ATTACK 147 0.0044
690 MACULAR DEGENERATION 52 0.0044
691 SOMNOLENCE 875 0.0043
692 HIP FRACTURE 139 0.0043
693 EYE DISORDER 142 0.0043
694 BALANCE DISORDER 373 0.0043
695 EMOTIONAL DISTRESS 522 0.0043
696 MICTURITION URGENCY 49 0.0043
697 EYE IRRITATION 246 0.0043
698 THERAPEUTIC RESPONSE DECREASED 259 0.0043
699 INCONTINENCE 45 0.0043
700 HYPOKALAEMIA 196 0.0042
701 INJECTION SITE INDURATION 55 0.0042
702 DRY THROAT 43 0.0042
703 IMMUNODEFICIENCY 63 0.0042
704 INTRAOCULAR PRESSURE INCREASED 54 0.0042
705 DEPRESSION 959 0.0042
706 TRANSFUSION 44 0.0042
707 TENDONITIS 65 0.0042
708 BLISTER 235 0.0042
709 KNEE ARTHROPLASTY 88 0.0042
710 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 141 0.0042
711 DEVICE ISSUE 374 0.0042
712 COLITIS 158 0.0042
713 SEROTONIN SYNDROME 80 0.0042
714 SKIN LESION 114 0.0042
715 DERMATITIS 87 0.0041
716 INJECTION SITE MASS 153 0.0041
717 MENTAL DISORDER 180 0.0041
718 BLOOD TEST ABNORMAL 58 0.0041
719 ABDOMINAL PAIN 958 0.0041
720 INCORRECT PRODUCT ADMINISTRATION DURATION 89 0.0041
721 SKIN DISORDER 137 0.0041
722 TOXICITY TO VARIOUS AGENTS 691 0.0041
723 DISABILITY 81 0.0041
724 LOCAL SWELLING 71 0.0041
725 RENAL FAILURE ACUTE 172 0.0040
726 DEVICE DEFECTIVE 70 0.0040
727 INJECTION SITE WARMTH 83 0.0040
728 HYPOPHAGIA 103 0.0040
729 ABDOMINAL PAIN UPPER 826 0.0040
730 LYMPHOMA 62 0.0040
731 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 285 0.0040
732 NIGHT SWEATS 129 0.0040
733 BLOOD URINE PRESENT 76 0.0040
734 END STAGE RENAL DISEASE 73 0.0040
735 CHRONIC KIDNEY DISEASE 304 0.0040
736 MEMORY IMPAIRMENT 548 0.0040
737 DERMATITIS ALLERGIC 50 0.0040
738 THIRST 71 0.0040
739 TENDON RUPTURE 49 0.0040
740 OSTEOARTHRITIS 168 0.0040
741 RENAL DISORDER 184 0.0039
742 BLOOD POTASSIUM INCREASED 64 0.0039
743 BASAL CELL CARCINOMA 61 0.0039
744 HYPERKALAEMIA 137 0.0039
745 GLAUCOMA 75 0.0039
746 MYALGIA 662 0.0039
747 NO THERAPEUTIC RESPONSE 47 0.0039
748 MALNUTRITION 43 0.0038
749 SKIN REACTION 54 0.0038
750 NO ADVERSE EVENT 693 0.0038
751 OSTEOPENIA 58 0.0038
752 DEPRESSED MOOD 202 0.0038
753 CRYING 138 0.0038
754 PLEURAL EFFUSION 231 0.0038
755 FACE OEDEMA 64 0.0038
756 OEDEMA PERIPHERAL 460 0.0038
757 ACUTE KIDNEY INJURY 576 0.0038
758 ASTHENIA 1400 0.0037
759 DEVICE LEAKAGE 161 0.0037
760 OFF LABEL USE 3250 0.0037
761 DIARRHOEA 2383 0.0037
762 SKIN EXFOLIATION 310 0.0037
763 POLLAKIURIA 152 0.0036
764 VISION BLURRED 499 0.0036
765 HAEMATEMESIS 92 0.0036
766 CHOLELITHIASIS 119 0.0036
767 INFLAMMATION 187 0.0036
768 GAIT INABILITY 121 0.0036
769 DRY SKIN 480 0.0036
770 INSOMNIA 957 0.0036
771 EXPOSURE VIA SKIN CONTACT 93 0.0036
772 APHASIA 108 0.0036
773 FLUID OVERLOAD 52 0.0036
774 ORAL PAIN 80 0.0036
775 ADVERSE REACTION 47 0.0035
776 HAEMORRHAGE 370 0.0035
777 JOINT SWELLING 426 0.0035
778 DRY MOUTH 286 0.0035
779 THERAPEUTIC RESPONSE UNEXPECTED 158 0.0035
780 BONE PAIN 206 0.0035
781 BONE DISORDER 64 0.0035
782 GAIT DISTURBANCE 672 0.0035
783 LYMPHOCYTE COUNT DECREASED 62 0.0035
784 ENCEPHALOPATHY 86 0.0035
785 BEDRIDDEN 46 0.0035
786 COGNITIVE DISORDER 163 0.0035
787 INCORRECT ROUTE OF DRUG ADMINISTRATION 124 0.0035
788 HOSPITALISATION 528 0.0034
789 DYSPEPSIA 338 0.0034
790 CEREBROVASCULAR ACCIDENT 580 0.0034
791 PRURITUS GENERALISED 74 0.0034
792 THERAPEUTIC PRODUCT EFFECT DECREASED 153 0.0034
793 RESPIRATORY ARREST 94 0.0034
794 JOINT STIFFNESS 89 0.0034
795 ORAL DISCOMFORT 47 0.0034
796 EMOTIONAL DISORDER 104 0.0034
797 MUSCULOSKELETAL STIFFNESS 295 0.0034
798 CHROMATURIA 76 0.0034
799 SKIN ULCER 87 0.0034
800 GASTROENTERITIS 49 0.0034
801 TASTE DISORDER 68 0.0033
802 CARDIAC FAILURE CONGESTIVE 268 0.0033
803 DRUG ADMINISTRATION ERROR 102 0.0033
804 HEMIPARESIS 56 0.0033
805 MUSCLE TWITCHING 76 0.0033
806 DIABETES MELLITUS 251 0.0033
807 HEPATIC FAILURE 99 0.0033
808 MUSCULOSKELETAL PAIN 172 0.0033
809 HOT FLUSH 247 0.0033
810 PANCREATITIS 173 0.0033
811 HIP ARTHROPLASTY 50 0.0033
812 AGITATION 239 0.0033
813 TYPE 2 DIABETES MELLITUS 109 0.0032
814 CONFUSIONAL STATE 523 0.0032
815 FAECES DISCOLOURED 70 0.0032
816 IMPAIRED HEALING 106 0.0032
817 JOINT RANGE OF MOTION DECREASED 43 0.0032
818 INCORRECT DOSE ADMINISTERED 729 0.0032
819 SENSORY DISTURBANCE 51 0.0032
820 PHARMACEUTICAL PRODUCT COMPLAINT 82 0.0032
821 HAEMOGLOBIN DECREASED 324 0.0032
822 ADVERSE DRUG REACTION 283 0.0031
823 CONSTIPATION 684 0.0031
824 PRODUCT PREPARATION ERROR 64 0.0031
825 DISTURBANCE IN ATTENTION 168 0.0031
826 GASTRIC ULCER 59 0.0031
827 UPPER GASTROINTESTINAL HAEMORRHAGE 52 0.0031
828 DYSSTASIA 90 0.0031
829 ARTHROPATHY 171 0.0031
830 PSYCHOMOTOR HYPERACTIVITY 51 0.0031
831 DECREASED APPETITE 705 0.0030
832 DRUG EFFECT INCOMPLETE 110 0.0030
833 SYRINGE ISSUE 53 0.0030
834 URINARY RETENTION 101 0.0030
835 RHABDOMYOLYSIS 126 0.0030
836 URINARY INCONTINENCE 89 0.0030
837 BLOOD TRIGLYCERIDES INCREASED 53 0.0030
838 PELVIC PAIN 54 0.0030
839 VISUAL IMPAIRMENT 368 0.0030
840 ABDOMINAL PAIN LOWER 75 0.0030
841 ILL-DEFINED DISORDER 180 0.0030
842 HYPERGLYCAEMIA 107 0.0029
843 UNDERDOSE 214 0.0029
844 BLOOD GLUCOSE ABNORMAL 54 0.0029
845 AMNESIA 190 0.0029
846 BLOOD GLUCOSE DECREASED 140 0.0029
847 DEAFNESS 76 0.0029
848 BLOOD ALKALINE PHOSPHATASE INCREASED 72 0.0029
849 HEPATIC ENZYME INCREASED 197 0.0029
850 MENTAL IMPAIRMENT 70 0.0029
851 NEOPLASM MALIGNANT 192 0.0029
852 DRUG INTERACTION 454 0.0029
853 DYSGEUSIA 212 0.0029
854 MOBILITY DECREASED 205 0.0029
855 BLINDNESS 116 0.0028
856 ANGER 96 0.0028
857 ANAEMIA 540 0.0028
858 HYPOTHYROIDISM 90 0.0028
859 MOVEMENT DISORDER 90 0.0028
860 NEUROTOXICITY 49 0.0028
861 FULL BLOOD COUNT DECREASED 56 0.0028
862 GLYCOSYLATED HAEMOGLOBIN INCREASED 70 0.0028
863 BLOOD CREATININE INCREASED 181 0.0028
864 PULMONARY FIBROSIS 53 0.0028
865 IRRITABILITY 166 0.0028
866 PARANOIA 47 0.0027
867 BLOOD LACTATE DEHYDROGENASE INCREASED 43 0.0027
868 GASTRIC DISORDER 93 0.0027
869 DEVICE BREAKAGE 110 0.0027
870 DRUG DOSE OMISSION BY DEVICE 211 0.0027
871 TREATMENT NONCOMPLIANCE 147 0.0027
872 SKIN IRRITATION 123 0.0027
873 WRONG TECHNIQUE IN DRUG USAGE PROCESS 97 0.0027
874 MULTIPLE SCLEROSIS 127 0.0027
875 RESTLESSNESS 97 0.0026
876 FRACTURE 50 0.0026
877 RASH GENERALISED 68 0.0026
878 DISORIENTATION 104 0.0026
879 HYPOGLYCAEMIA 127 0.0026
880 MYOCARDIAL INFARCTION 456 0.0026
881 ORTHOSTATIC HYPOTENSION 45 0.0026
882 CORONARY ARTERY DISEASE 78 0.0026
883 CEREBRAL HAEMORRHAGE 92 0.0026
884 PRODUCT COMPLAINT 65 0.0026
885 OVERDOSE 553 0.0026
886 PAIN OF SKIN 69 0.0026
887 FEMUR FRACTURE 79 0.0025
888 LABORATORY TEST ABNORMAL 75 0.0025
889 FLATULENCE 144 0.0025
890 STOMATITIS 154 0.0025
891 C-REACTIVE PROTEIN INCREASED 92 0.0025
892 CARDIAC FAILURE 202 0.0025
893 DYSKINESIA 102 0.0025
894 HEPATIC CIRRHOSIS 47 0.0025
895 SUICIDAL IDEATION 226 0.0025
896 PNEUMONITIS 67 0.0025
897 DELIRIUM 85 0.0024
898 INTENTIONAL PRODUCT MISUSE 214 0.0024
899 ANGINA PECTORIS 70 0.0024
900 GASTROINTESTINAL HAEMORRHAGE 204 0.0024
901 RHEUMATOID ARTHRITIS 277 0.0024
902 FOETAL EXPOSURE DURING PREGNANCY 196 0.0024
903 VISUAL ACUITY REDUCED 80 0.0024
904 INCREASED APPETITE 46 0.0024
905 SEDATION 63 0.0024
906 DRUG INTOLERANCE 231 0.0024
907 BLOOD CHOLESTEROL INCREASED 111 0.0024
908 THERAPY CESSATION 122 0.0024
909 ASPARTATE AMINOTRANSFERASE INCREASED 126 0.0024
910 THINKING ABNORMAL 44 0.0024
911 CYTOKINE RELEASE SYNDROME 47 0.0023
912 PRODUCT DISPENSING ERROR 51 0.0023
913 HYPOACUSIS 100 0.0023
914 ALTERED STATE OF CONSCIOUSNESS 50 0.0023
915 MOUTH ULCERATION 48 0.0023
916 MOOD ALTERED 62 0.0023
917 PSORIATIC ARTHROPATHY 92 0.0023
918 DEVICE DELIVERY SYSTEM ISSUE 62 0.0023
919 SUICIDE ATTEMPT 137 0.0023
920 BLOOD BILIRUBIN INCREASED 61 0.0023
921 ALOPECIA 441 0.0022
922 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 451 0.0022
923 PANCREATITIS ACUTE 50 0.0022
924 ASCITES 65 0.0022
925 LIVER DISORDER 97 0.0022
926 THROMBOCYTOPENIA 243 0.0022
927 FEBRILE NEUTROPENIA 144 0.0022
928 ALANINE AMINOTRANSFERASE INCREASED 132 0.0021
929 LIVER FUNCTION TEST INCREASED 46 0.0021
930 MOOD SWINGS 68 0.0021
931 AGEUSIA 53 0.0021
932 PLATELET COUNT DECREASED 225 0.0021
933 GENERAL PHYSICAL HEALTH DETERIORATION 243 0.0021
934 DRUG DOSE OMISSION 347 0.0021
935 PRODUCT STORAGE ERROR 183 0.0021
936 ABNORMAL BEHAVIOUR 82 0.0021
937 PRODUCT SUBSTITUTION ISSUE 119 0.0021
938 DRUG EXPOSURE DURING PREGNANCY 70 0.0021
939 ABNORMAL DREAMS 56 0.0020
940 PRODUCT DOSE OMISSION 132 0.0020
941 BLOOD CREATINE PHOSPHOKINASE INCREASED 58 0.0020
942 GLOSSODYNIA 45 0.0020
943 LIVER FUNCTION TEST ABNORMAL 58 0.0020
944 EXTRA DOSE ADMINISTERED 80 0.0020
945 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 92 0.0020
946 WHITE BLOOD CELL COUNT DECREASED 213 0.0020
947 MUCOSAL INFLAMMATION 51 0.0019
948 INCORRECT DOSE ADMINISTERED BY DEVICE 51 0.0019
949 DEMENTIA 54 0.0019
950 PSYCHOTIC DISORDER 57 0.0019
951 INTERNATIONAL NORMALISED RATIO INCREASED 55 0.0019
952 SKIN BURNING SENSATION 137 0.0019
953 PRODUCT PRESCRIBING ERROR 45 0.0019
954 TREATMENT FAILURE 156 0.0019
955 HAEMATURIA 64 0.0019
956 CEREBRAL INFARCTION 45 0.0018
957 HEPATITIS 47 0.0018
958 AGGRESSION 90 0.0018
959 ABORTION SPONTANEOUS 71 0.0018
960 CONVULSION 101 0.0018
961 WITHDRAWAL SYNDROME 74 0.0018
962 PSORIASIS 227 0.0017
963 ACNE 130 0.0017
964 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 120 0.0017
965 DRUG EFFECT DECREASED 90 0.0017
966 BLOOD GLUCOSE INCREASED 306 0.0016
967 OSTEONECROSIS 53 0.0016
968 DEATH 1383 0.0016
969 HYPONATRAEMIA 90 0.0016
970 MULTIPLE SCLEROSIS RELAPSE 106 0.0015
971 DEVICE DISLOCATION 67 0.0015
972 NEUTROPHIL COUNT DECREASED 62 0.0015
973 CONTRAINDICATED PRODUCT ADMINISTERED 44 0.0015
974 HALLUCINATION 109 0.0014
975 PANCYTOPENIA 79 0.0014
976 PLASMA CELL MYELOMA 54 0.0014
977 ADVERSE EVENT 124 0.0013
978 DISEASE PROGRESSION 157 0.0013
979 DEVICE DIFFICULT TO USE 85 0.0013
980 BREAST CANCER 116 0.0012
981 NEUTROPENIA 168 0.0012
982 VAGINAL HAEMORRHAGE 53 0.0012
983 LUNG NEOPLASM MALIGNANT 50 0.0012
984 LEUKOPENIA 59 0.0012
985 INTERSTITIAL LUNG DISEASE 51 0.0011
986 DISEASE RECURRENCE 48 0.0010
987 DRUG ABUSE 65 0.0008
988 MALIGNANT NEOPLASM PROGRESSION 73 0.0007
989 DRUG WITHDRAWAL SYNDROME 62 0.0007
990 COMPLETED SUICIDE 51 0.0006
991 PROSTATE CANCER 45 0.0006
992 DRUG DEPENDENCE 77 0.0005